PMA device
Glucowatch G2 Biographer
Animas Corp. · Instrument, Glucose, Noninvasive Technology (NCT, Class III) · First FDA decision Aug 28, 2003, newest Feb 25, 2004Diabetes
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
3
Naming "Glucowatch G2 Biographer"
MAUDE reports
0
Brand "Glucowatch G2 Biographer", since 2015
PubMed studies
15
Mentioning "Glucowatch G2 Biographer"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Glucowatch G2 Biographer
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- GLUCOWATCH G2 BIOGRAPHERPMA supplement
P990026-S021 · Decided Feb 25, 2004 · 147 days after receipt · Normal 180 Day Track
Device type: INSTRUMENT, GLUCOSE, NONINVASIVE TECHNOLOGY (NCT) · Laboratory Medicine & Pathology
- GLUCOWATCH G2 BIOGRAPHERPMA supplement
P990026-S019 · Decided Aug 28, 2003 · 52 days after receipt · Normal 180 Day Track No User Fee
Device type: INSTRUMENT, GLUCOSE, NONINVASIVE TECHNOLOGY (NCT) · Laboratory Medicine & Pathology
P990026-S018 · Decided Nov 20, 2003 · 142 days after receipt · Normal 180 Day Track
Device type: INSTRUMENT, GLUCOSE, NONINVASIVE TECHNOLOGY (NCT) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Glucowatch G2 Biographer", any status and sponsor, newest update first.
- Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch BiographerPivotal-lookingCompleted
Jaeb Center for Health ResearchAcademic, hospital or other
NCT00069628 · 200 participants · Start Jul 2003
Device: GlucoWatch® G2™ Biographer (GW2B); Continuous Glucose Monitoring System (CGMS) · For: Diabetes Mellitus, Insulin-Dependent
Sites: Stanford, California; Denver, Colorado; New Haven, Connecticut · 6 sites in all
- Pilot Study of the GlucoWatch G2 Biographer for the Management of Type 1 Diabetes in ChildrenCompleted
Jaeb Center for Health ResearchAcademic, hospital or other
NCT00069615 · 15 participants · Start Feb 2003
Device: GlucoWatch® G2™ Biographer (GW2B); Continuous Glucose Monitoring System™ (CGMS) · For: Diabetes Mellitus, Insulin-Dependent
Sites: Stanford, California; Denver, Colorado; New Haven, Connecticut · 6 sites in all
Jaeb Center for Health ResearchAcademic, hospital or other
NCT00069537 · 90 participants · Start May 2002
Device: The GlucoWatch® G2™ Biographer (GW2B); The Continuous Glucose Monitoring System (CGMS™) · For: Diabetes Mellitus, Insulin-Dependent
Sites: Stanford, California; Denver, Colorado; New Haven, Connecticut · 6 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Glucowatch G2 Biographer", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NCT
3 reports: 3 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Glucowatch G2 Biographer"[tiab]. The summary above synthesizes these.
- GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children.
Tsalikian E, Kollman C, Mauras N, et al. · Diabetes Technol Ther · 2004Research Support, U.S. Gov't, P.H.S.
- Home use of the GlucoWatch G2 biographer in children with diabetes.
Hathout E, Patel N, Southern C, et al. · Pediatrics · 2005Evaluation Study
- Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: experience of the Diabetes Research in Children Network.
Diabetes Care · 2004
- The accuracy of the GlucoWatch G2 biographer in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study.
Diabetes Technol Ther · 2003Clinical Trial, Comparative Study
- Transdermal reverse iontophoresis: A novel technique for therapeutic drug monitoring.
Giri TK, Chakrabarty S, Ghosh B · J Control Release · 2017Review, Research Support, Non-U.S. Gov't
- Function of the GlucoWatch G2 Biographer during exercise.
Tsalikian E, Beck RW, Kalajian A, et al. · Diabetes Technol Ther · 2005Comment, Letter
- Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes.
Diabetes Care · 2005Clinical Trial, Multicenter Study
- The effect of preapplication of corticosteroids on skin irritation and performance of the GlucoWatch G2 Biographer.
Tamada JA, Davis TL, Leptien AD, et al. · Diabetes Technol Ther · 2004Clinical Trial, Randomized Controlled Trial
- Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA(1c) in insulin-treated diabetes (MITRE Study).
Cooke D, Hurel SJ, Casbard A, et al. · Diabet Med · 2009Multicenter Study, Randomized Controlled Trial
- Development and piloting of an acceptability questionnaire for continuous glucose monitoring devices.
Steed L, Cooke D, Hurel SJ, et al. · Diabetes Technol Ther · 2008Research Support, Non-U.S. Gov't, Validation Study
- A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes.
Chase HP, Beck R, Tamborlane W, et al. · Diabetes Care · 2005Clinical Trial, Comparative Study
- Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes.
Pediatr Diabetes · 2006Multicenter Study, Randomized Controlled Trial
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.